Literature DB >> 18295717

Transient cell proliferation with polyethylenimine-cationized N-terminal domain of simian virus 40 large T-antigen.

Hitoshi Murata1, Junichiro Futami, Midori Kitazoe, Megumi Kosaka, Hiroko Tada, Masaharu Seno, Hidenori Yamada.   

Abstract

Polyethylenimine (PEI) cationization is a powerful strategy for protein transduction into cells. In this study, we attempted the artificial regulation of cell proliferation by protein transduction of the N-terminal domain (1-132 amino acids) of the simian virus 40 large T-antigen (SVLT-N), which inactivates retinoblastoma family proteins but not p53. To deliver SVLT-N into cells, we employed an indirect cationization method by forming a complex of biotynylated SVLT-N through disulfide bonds (biotin-SS-SVLT-N) and PEI-cationized avidin (PEI600-avidin). Using this complex, SVLT-N was transduced into the nucleus of confluent and quiescent Balb/c 3T3 cells and was found to be complexed with a cellular target protein, pRb. Furthermore, SVLT-N transduction induced cell proliferation in spite of confluent conditions. Because SVLT-N thus transduced into cells gradually degraded and was not detectable after a 4-d incubation, transiently transformed cells were obtained by this method. These results suggest that oncogene protein transduction technology has great potential for in vitro regulation of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18295717     DOI: 10.1263/jbb.105.34

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  2 in total

Review 1.  Protein transfection via spherical nucleic acids.

Authors:  Sasha B Ebrahimi; Devleena Samanta; Caroline D Kusmierz; Chad A Mirkin
Journal:  Nat Protoc       Date:  2022-01-17       Impact factor: 13.491

2.  An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice.

Authors:  Yu-Sung Cheng; Zih-Ten Chen; Tai-Yan Liao; Chen Lin; Howard C-H Shen; Ya-Han Wang; Chi-Wei Chang; Ren-Shyan Liu; Rita P-Y Chen; Pang-Hsien Tu
Journal:  EMBO Mol Med       Date:  2017-05       Impact factor: 12.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.